| インド | トルコ | オーストリア | |
| 高密度焦点式超音波焼灼術 | から $4,200 | から $4,000 | から $12,000 |
| 陽子線治療 | から $25,000 | から $70,000 | から $80,000 |
| 陽子線治療 | から $35,000 | から $30,000 | から $80,000 |
| 膵頭十二指腸切除術 | から $7,500 | から $23,000 | から $45,000 |
| 腹腔内温熱化学療法 | から $9,500 | から $22,500 | から $40,000 |
Bookimedは腺癌治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。腺癌治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。腺癌治療の旅路でお一人になることはありません。
この医師は、HCG Manavata Cancer Centreで12年間の経験を持つ熟練した核医学専門医です。医師は、さまざまな核スキャン、PET-CTスキャン、および核心臓病学サービスを専門としており、放射性ヨウ素およびLu-177 RN療法において熟練しています。キャリアの中で、医師は30,000件以上のPETスキャンを管理し、1,000人以上の甲状腺癌患者を治療してきました。さらに、医師はさまざまな医学雑誌に論文を発表することで、この分野に貢献しています。
この医師は、高度な技術を持つ腫瘍専門医であり、固形腫瘍、小児腫瘍、血液悪性腫瘍を含むさまざまな癌の治療を専門としています。彼女は、ウィップル手術などの保守的および外科的治療の両方に精通しています。<\/p>
彼女はLady Hardinge Medical CollegeでMBBSを取得し、Maulana Azad Medical Collegeで内科のMDを取得しました。その後、Tata Memorial HospitalでDM医療腫瘍学を追求し、そこでコンサルタントとしても勤務しました。<\/p>
彼女は国際的および国内の腫瘍学会に所属しており、肺、乳房、婦人科、泌尿生殖器の癌に関する専門知識を持ち、免疫療法とメトロノミック療法に特に関心を持っています。<\/p>
Indian oncologists treating adenocarcinoma frequently hold international accreditations from respected global organizations. Many specialists earn certifications from the European Society for Medical Oncology (ESMO) or the American Society of Clinical Oncology (ASCO). Leading facilities maintain Joint Commission International (JCI) standards for safety.
Bookimed Expert Insight: Quality signals in India often follow a hub-and-spoke pattern. Major medical hubs like Gurgaon and Chennai house hospitals like Fortis and Global Hospital. These facilities report massive volumes, sometimes serving over 80,000 patients annually. Our data shows that high-volume surgeons, such as those at HCG Manavata with over 50,000 procedures, are those most likely to hold multiple international fellowships.
Patient Consensus: Patients note it is vital to travel to major cities for accredited care. They emphasize that video consultations help verify a doctor's global credentials before traveling.
India enforces safety for chemotherapy and radiation through statutory regulations from the Atomic Energy Regulatory Board and the National Cancer Grid. Facilities like Global Hospital Chennai and Manipal Hospital maintain JCI and NABH accreditations. These standards mandate precise tumor targeting and strict waste management protocols.
Bookimed Expert Insight: Quality indicators for safety are closely tied to specialist experience and clinical volume rather than just equipment. At HCG Manavata Cancer Centre, specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries. This massive clinical volume allows institutions to refine safety checklists that common regulations might overlook.
Patient Consensus: Patients note that safety standards can vary significantly between facility tiers. They emphasize checking for current NABH or JCI accreditations before starting any long-term oncology treatment.
Indian oncology centers manage adenocarcinoma side effects using protocols from the National Cancer Grid and international standards. Support involves preventive nausea control with serotonin antagonists and specialized radiation skin care. Facilities like Artemis Hospitals and Medanta follow strict monitoring for toxicity and blood counts.
Bookimed Expert Insight: High-volume centers like HCG Manavata Cancer Centre, which serves 75,000 patients annually, integrate surgical and medical expertise to preemptively manage toxicity. Specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries, emphasizing that experienced clinical teams often catch side effects earlier than smaller facilities. This proactive monitoring is key in large, JCI-accredited Indian hospitals.
Patient Consensus: Patients emphasize starting mouth and skin care regimens on day 1 to prevent severe reactions. Many suggest using natural alternatives like ginger tea for nausea and curd rice for managing digestive issues during radiation.
Smaller Indian cities like Nashik, Mohali, and Nadiad offer the shortest wait times for adenocarcinoma surgery. Private facilities in these hubs often schedule robotic or laparoscopic procedures in under 7 days. Major metros like Gurgaon and Bangalore maintain high-capacity systems with 7 to 20-day access.
Bookimed Expert Insight: While major metros have more robots, tier-2 cities like Nashik provide faster surgical slots due to lower international patient density. Dr. Raj Nagarkar in Nashik has performed over 50,000 surgeries. This high individual volume in smaller hubs often ensures both speed and significant surgical expertise.
Patient Consensus: Patients find that booking multiple consultations in cities like Mumbai or Delhi can secure a robotic slot within 10 days. Those choosing underrated hubs like Hyderabad report getting surgery dates in as little as 5 days post-biopsy.
A full adenocarcinoma treatment cycle in India typically requires 4 to 12 weeks. Stays vary by modality: surgery alone takes 2 to 6 weeks, while radiation requires 3 to 6 weeks. Combined protocols involving chemotherapy and surgery often extend stays to 3 months for safety.
Bookimed Expert Insight: High-volume centers like HCG Manavata or Global Hospital serve up to 80,000 patients yearly. This massive volume allows them to offer fast-track diagnostic bundles. Patients can often complete CT scans and oncology consultations within 48 hours. Using centers with 40+ staff oncologists typically shortens the pre-treatment phase by at least 1 week.
Patient Consensus: Patients note that lung or breast cancer cycles often hit the 10-week mark. It is important to pack for 2 months and book flexible flights to account for recovery buffers.
Continuing targeted therapy in India is generally feasible. Standard treatments like immunotherapy or tyrosine kinase inhibitors are available at major oncology centers. Global clinical trials however require specific approval from the study sponsor. The Indian facility must already be a registered site for that trial.
Bookimed Expert Insight: Private oncology centers in India offer a significant advantage for continuing complex care. Specialized facilities like HCG Manavata Cancer Centre participate in over 200 clinical trials. Dr. Raj Nagarkar there has extensive experience managing phase 1-3 studies. Choosing a center with high trial volume ensures the infrastructure for protocol continuity exists.
Patient Consensus: Patients note that switching trials often requires re-enrollment rather than a seamless transfer. Accessing targeted drugs is easier if you budget for potential 4–6 week import delays at customs.